학술논문

Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial
Document Type
Article
Source
In International Journal of Radiation Oncology, Biology, Physics 1 April 2021 109(5):1176-1184
Subject
Oligometastases
Language
ISSN
0360-3016